Single cell sequencing revealed the mechanism of PD-1 resistance affected by the expression profile of peripheral blood immune cells in ESCC
暂无分享,去创建一个
R. Liu | Y. Ba | T. Deng | Huiya Wang | M. Bai | Shaohua Ge | Tao Ning | Le Zhang | Haiyang Zhang | Changliang Yang | Mengsi Zuo | Zhi Ji | Junyi Wang
[1] Y. Kakeji,et al. Metallothionein 2A Expression in Cancer-Associated Fibroblasts and Cancer Cells Promotes Esophageal Squamous Cell Carcinoma Progression , 2021, Cancers.
[2] Sung-Bae Kim,et al. Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study , 2021, The Lancet.
[3] Yongjin P. Park. Faculty Opinions recommendation of SCENIC: single-cell regulatory network inference and clustering. , 2021, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.
[4] Xianjun Yu,et al. Applications of single-cell sequencing in cancer research: progress and perspectives , 2021, Journal of Hematology & Oncology.
[5] R. DePinho,et al. Single-cell RNA sequencing in pancreatic cancer , 2021, Nature Reviews Gastroenterology & Hepatology.
[6] M. Spitzer,et al. Systemic immunity in cancer , 2021, Nature Reviews Cancer.
[7] K. Livak,et al. Applying high-dimensional single-cell technologies to the analysis of cancer immunotherapy , 2020, Nature Reviews Clinical Oncology.
[8] Jian Cao,et al. Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment , 2020, Nature Communications.
[9] Amy Y. Chen,et al. Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity , 2020, Journal of Hematology & Oncology.
[10] Jing-mei Liu,et al. Comprehensive analysis of partial epithelial mesenchymal transition‐related genes in hepatocellular carcinoma , 2020, Journal of cellular and molecular medicine.
[11] Sung-Bae Kim,et al. Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] Zhong Chen,et al. Identification of MT1E as a novel tumor suppressor in hepatocellular carcinoma. , 2020, Pathology, research and practice.
[13] A. Maitra,et al. Interleukin-17–induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer , 2020, The Journal of experimental medicine.
[14] Erin L. Schenk,et al. Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing , 2020, Cell.
[15] U. Khan,et al. Role of Immune Checkpoint Inhibitors in Gastrointestinal Malignancies , 2020, Journal of clinical medicine.
[16] K. Sun,et al. Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors , 2020, Frontiers in Cell and Developmental Biology.
[17] Weidong Li,et al. MT2A Promotes Oxaliplatin Resistance in Colorectal Cancer Cells , 2020, Cell Biochemistry and Biophysics.
[18] Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.
[19] J. Ferlay,et al. Global burden of oesophageal and gastric cancer by histology and subsite in 2018 , 2020, Gut.
[20] D. Lambrechts,et al. A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling , 2020, Cell Research.
[21] Shuofeng Hu,et al. Dissecting transcriptional heterogeneity in primary gastric adenocarcinoma by single cell RNA sequencing , 2020, Gut.
[22] K. Tarte,et al. Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer. , 2020, Cancer discovery.
[23] Hongyu Zhao,et al. Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors , 2020, Nature Medicine.
[24] E. Smyth,et al. A global perspective on oesophageal cancer: two diseases in one. , 2020, The lancet. Gastroenterology & hepatology.
[25] X. Jia,et al. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis , 2020, Molecular Cancer.
[26] Hanlee P. Ji,et al. Single-Cell Genomic Characterization Reveals the Cellular Reprogramming of the Gastric Tumor Microenvironment , 2020, Clinical Cancer Research.
[27] Jun Liu,et al. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma , 2020, Aging.
[28] Piyushkumar A. Mundra,et al. Immune-awakening revealed by peripheral T cell dynamics after one cycle of immunotherapy , 2019, Nature Cancer.
[29] G. Bregni,et al. PD-1 and PD-L1 inhibitors in oesophago-gastric cancers. , 2020, Cancer letters.
[30] Andrew D. Smith,et al. Falco: high-speed FastQC emulation for quality control of sequencing data. , 2019, F1000Research.
[31] Sung-Bae Kim,et al. Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial. , 2019, The Lancet. Oncology.
[32] K. Almstedt,et al. The active role of the transcription factor Sp1 in NFATc2-mediated gene regulation in pancreatic cancer , 2019, BMC Biochemistry.
[33] P. Wen,et al. Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma , 2018, Nature Medicine.
[34] Fan Zhang,et al. Fast, sensitive, and accurate integration of single cell data with Harmony , 2018, bioRxiv.
[35] Burak Dura,et al. scFTD-seq: freeze-thaw lysis based, portable approach toward highly distributed single-cell 3′ mRNA profiling , 2018, Nucleic acids research.
[36] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[37] Haiyang Xie,et al. Metallothionein 1 family profiling identifies MT1X as a tumor suppressor involved in the progression and metastastatic capacity of hepatocellular carcinoma , 2018, Molecular carcinogenesis.
[38] J. Lang,et al. The roles of metallothioneins in carcinogenesis , 2018, Journal of Hematology & Oncology.
[39] Boxi Kang,et al. Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing , 2018, Nature Medicine.
[40] Johan Hartman,et al. Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing , 2018, Cell.
[41] Paul Hoffman,et al. Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.
[42] S. Pushalkar,et al. The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. , 2018, Cancer discovery.
[43] Jia Gu,et al. fastp: an ultra-fast all-in-one FASTQ preprocessor , 2018, bioRxiv.
[44] Reinhard Dummer,et al. High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy , 2018, Nature Network Boston.
[45] J. Lunceford,et al. Safety and Antitumor Activity of the Anti-Programmed Death-1 Antibody Pembrolizumab in Patients With Advanced Esophageal Carcinoma. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[46] Alexander E. Kel,et al. cutPrimers: A New Tool for Accurate Cutting of Primers from Reads of Targeted Next Generation Sequencing , 2017, J. Comput. Biol..
[47] T. McGaha,et al. Type I Interferon in Chronic Virus Infection and Cancer. , 2017, Trends in immunology.
[48] J. Aerts,et al. SCENIC: Single-cell regulatory network inference and clustering , 2017, Nature Methods.
[49] Sydney M. Shaffer,et al. Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance , 2017, Nature.
[50] S. Chi,et al. Identification of XAF1–MT2A mutual antagonism as a molecular switch in cell-fate decisions under stressful conditions , 2017, Proceedings of the National Academy of Sciences.
[51] L. J. K. Wee,et al. Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors , 2017, Nature Genetics.
[52] Andrew J. Hill,et al. Single-cell mRNA quantification and differential analysis with Census , 2017, Nature Methods.
[53] K. Haustermans,et al. Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.
[54] A. Regev,et al. Spatial reconstruction of single-cell gene expression , 2015, Nature Biotechnology.
[55] P. Rosenstiel,et al. c-Rel is a critical mediator of NF-κB-dependent TRAIL resistance of pancreatic cancer cells , 2014, Cell Death and Disease.
[56] Wei Shi,et al. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..
[57] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[58] Guangchuang Yu,et al. clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.
[59] Anjana Rao,et al. NFAT, immunity and cancer: a transcription factor comes of age , 2010, Nature Reviews Immunology.
[60] Loise M. Francisco,et al. The PD‐1 pathway in tolerance and autoimmunity , 2010, Immunological reviews.
[61] K. Williams,et al. Evaluation of a 12‐color flow cytometry panel to study lymphocyte, monocyte, and dendritic cell subsets in humans , 2010, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[62] S. Garrett,et al. Basal and metal‐induced expression of metallothionein isoform 1 and 2 genes in the RWPE‐1 human prostate epithelial cell line , 2008, Journal of applied toxicology : JAT.
[63] G. Freeman,et al. PD-1 and its ligands in tolerance and immunity. , 2008, Annual review of immunology.
[64] G. Freeman,et al. The B7–CD28 superfamily , 2002, Nature Reviews Immunology.
[65] M. Ebadi,et al. Free radical scavenging actions of metallothionein isoforms I and II. , 1998, Free radical research.